The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers
NCT ID: NCT06174506
Last Updated: 2023-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2023-12-01
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives of the study:
1. To survey some risk factors for atrial fibrillation in patients with permanent pacemakers.
2. To determine the role of hs Troponin I and NT-proBNP in predicting new-onset atrial fibrillation within follow-up time.
3. To build a model to predict the prognosis of atrial fibrillation based on the detected subclinical markers related to atrial fibrillation and classic cardiovascular risk factors.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The hs troponin I and NT-proBNP tests will be performed before the patient has a pacemaker.
The two tests above will be paid by research team. Patients do not have to pay for these tests.
Atrial fibrillation will be determined through ECG, holter ECG and pacemaker data.
Time to follow up patients in the study: According to the patient's follow-up visits after pacemaker placement: 1 month, 3 months, 6 months, then every 6 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with pacemakers without atrial fibrillation at the beginning or in history
Patients with pacemakers without atrial fibrillation at the beginning or in history.
Patients are adults over 18 years old.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* There is indication for permanent pacemaker placement and patient agreement to permanent pacemaker placement
* Patient agrees to participate in the study
Exclusion Criteria
* Severe patients, at risk of death
* Pregnant
* The patient is indicated for surgery
* Patients with eGFR ≤ 30 mL/min/1.73m2
* The patient has a serious infection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Medicine and Pharmacy at Ho Chi Minh City
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linh Ha Khanh Duong
Duong Ha Khanh Linh
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linh HK Duong, Master
Role: PRINCIPAL_INVESTIGATOR
Cho Ray Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cho Ray Hospital
Ho Chi Minh City, None Selected, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Thuc T Nguyen, PhD, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
806/HDDD-DHYD
Identifier Type: -
Identifier Source: org_study_id